Small Cap Stocks To Follow Now – May 17th

Cerebras Systems, AltC Acquisition, P3 Health Partners, Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock, HCW Biologics, Inflection Point Acquisition, and Direxion Daily MSFT Bull 2X Shares are the seven Small Cap stocks to watch today, according to MarketBeat’s stock screener tool. Small cap stocks are shares of publicly traded companies with relatively small market capitalizations, typically ranging from about $300 million to $2 billion. For stock market investors, they are often seen as higher-risk, higher-growth opportunities compared with larger companies, since they can be more volatile but also have greater potential for rapid expansion. These companies had the highest dollar trading volume of any Small Cap stocks within the last several days.

Cerebras Systems (CBRS)

We are building the fastest AI infrastructure in the world. In AI, speed is critical to win. Speed improves user engagement, expands product capabilities, can lower operating costs, and opens new markets. It shortens iteration cycles for engineers, researchers, and professionals across industries, allowing them to be more productive.

AltC Acquisition (ALCC)

AltC Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was formerly known as Churchill Capital Corp VIII and changed its name to AltC Acquisition Corp.

P3 Health Partners (PIII)

P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada.

Strategy Inc Variable Rate Series A Perpetual Stretch Preferred Stock (STRC)

Strategy Inc is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provides industry AI-powered enterprise analytics software.

HCW Biologics (HCWB)

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases.

Inflection Point Acquisition (IPAX)

Direxion Daily MSFT Bull 2X Shares (MSFU)